Post on 22-Sep-2020
9/13/2019
1
Gastroesophageal Reflux in
Neonates and Infants
Thomas N. George, MD FAAPSystem Director, Neonatology, Children’s Minnesota
Professor of Pediatrics, University of Minnesota
Minnesota Perinatal Organization
45th Annual Conference
September 19.2019
© 2019 2
Children’s Minnesota
Disclaimers and Confidentiality Protections
Children’s Minnesota makes no representations or warranties about the accuracy, reliability, or completeness of the
content. Content is provided “as is” and is for informational use only. It is not a substitute for professional medical
advice, diagnosis, or treatment. Children’s disclaims all warranties, express or implied, statutory or otherwise,
including without limitation the implied warranties of merchantability, non-infringement of third parties’ rights, and
fitness for a particular purpose.
This content was developed for use in Children’s patient care environment and may not be suitable for use in other
patient care environments. Children’s does not endorse, certify, or assess third parties’ competency. You hold all
responsibility for your use or nonuse of the content. Children’s shall not be liable for claims, losses, or damages
arising from or related to any use or misuse of the content.
This content and its related discussions are privileged and confidential under Minnesota’s peer review statute (Minn.
Stat. § 145.61 et. seq.). Do not disclose unless appropriately authorized. Notwithstanding the foregoing, content
may be subject to copyright or trademark law; use of such information requires Children’s permission.
This content may include patient protected health information. You agree to comply with all applicable state and
federal laws protecting patient privacy and security including the Minnesota Health Records Act and the Health
Insurance Portability and Accountability Act and its implementing regulations as amended from time to time.
Please ask if you have any questions about these disclaimers and/or confidentiality protections.
© 2019 3
Take home points
• Gastroesophageal reflux is a frequent occurrence in all newborns, especially preterm newborns
• Avoid the “pathologizing” of this normal developmental phenomenon
• There is no role for medications for GER in premature infants
• Manipulations of feedings has minimal impact, and can be detrimental
• Strive to have all infants on their back to sleep, with head of the bed flat starting at 32 weeks
9/13/2019
2
© 2019 4
Objectives
• To identify signs of neonatal and infant
gastroesophageal reflux (GER)
• To describe the difference between GER and GER
disease
• To describe effective and ineffective therapies of
neonatal and infant GER
© 2019 5
Gastroesophageal Reflux (GER)
Definition:
• The involuntary passage of gastric contents into the
esophagus
• “Happy Barfers”!!!
© 2019 6
GER
Normal physiological process
• Transient lower esophageal sphincter relaxation
(TLESR)
• Unrelated to swallowing and of relatively longer
duration than the relaxation triggered by a swallow
Most common visible symptoms
• Regurgitation and spitting up
9/13/2019
3
© 2019 7
GER
© 2019 8
GER Signs: Regurgitation/vomiting
Differential:
• Sepsis
• Sepsis
• Sepsis
© 2019 9
GER Signs: Regurgitation/vomitingDifferential:
• Bowel obstruction –
• bilious could be from volvulus
• non-bilious would be more distal obstruction
• NEC
• Medications eg caffeine
9/13/2019
4
© 2019 10
GER Signs: Regurgitation/vomitingDifferential:
• Pyloric Stenosis
• Inborn errors of metabolism
© 2019 11
GER – Term infants
Term babies
• Some babies/infants throw up after almost every
feedings, and many times between feedings
• ~70-85% of infants have reflux in the first 2 months
of life
• GER peaks at ~ 4 months of age, resolves by 12 –
18 months
• In one study, 10% of babies in a well baby clinic had
signs of GER
© 2019 12
GER – Preterm infants
• Common diagnosis in the NICU
• Large variation in how it is diagnosed and treated
• Diagnosis is typically made by clinical/behavioral
signs
• Documented that preterm infants have dozens of
episodes of TLESR every day
9/13/2019
5
© 2019 13
• NG/OG tube through the LES can increase the
frequency of GER
• GER is more common immediately after feeding, likely
due to gastric distention
GER – Preterm infants
© 2019 14
• Prone positioning decreases GER versus supine
positioning
• If reflux reaches the upper esophagus, the Upper
Esophageal Sphincter reflexively opens and allows
material to enter the pharynx
• Results in frequent spitting up/emesis
GER – Preterm infants
© 2019 15
Gastroesophageal Reflux Disease (GERD)
When there are clinical consequences of GER:
• Acidic contents of stomach reflux into esophagus
and create potential to irritate and damage
mucosal surfaces from acid
9/13/2019
6
© 2019 16
Gastroesophageal Reflux Disease (GERD)
When there are clinical consequences of GER:
• Failure to thrive from excessive emesis
• Bleeding
• Respiratory problems with frequent
coughing/recurrent aspiration or pneumonia
© 2019 17
Gastroesophageal Reflux Disease (GERD)
Treatment options may involve
• H2 blockers eg ranitidine
• PPI eg omeprazole
© 2019 18
Less likely in preterm infants:
• GER is only weakly acidic because of lower gastric
acid and frequent milk feedings
Gastroesophageal Reflux Disease (GERD)
9/13/2019
7
© 2019 19
GER - Diagnosis
Clinically
• Clinical and behavioral signs felt to be associated
with GER: feeding intolerance, apnea, bradycardia,
desaturation
• Nonspecific behavioral signs felt to be associated
with GER : arching, irritability, apparent discomfort
with feedings
© 2019 20
Contrast study
• Doesn’t differentiate
between clinically
significant GER
from insignificant
GER
• One moment in
time
GER - Diagnosis
© 2019 21
pH probe study
• Typically used in older children and adults
GER - Diagnosis
9/13/2019
8
© 2019 22
Multichannel Intraesophageal Impedance (MII)
• Most accurate method, reliable and reproducible
GER - Diagnosis
© 2019 23
GER and Clinical events
MII-pH (Funderburk et al)
• Prevalence of significant detected GER was low
• Majority of suspected clinical reflux behaviors did
NOT correlate directly to actual reflux
• Temporal relationship between:
• Irritability and reflux: 19%
• Bradycardia and reflux: 5%
• Gagging and reflux: 57%
© 2019 24
• Frequency of apnea during reflux was the same as
periods that were reflux free
• GER does not prolong or worsen apnea
GER and Clinical events
9/13/2019
9
© 2019 25
GER – Treatment
Body positioning
• Head up angle – commonly used therapy
• Ineffective in reducing acid reflux
© 2019 26
Body positioning
• LLR and prone positioning – reduces vomiting –
other signs did not change
• LLR/prone is not consistent with positioning for SIDS
prevention
• Babies should be on monitors continuously
GER – Treatment
© 2019 27
AAP and NASPGN – recommend supine sleep
position
• to reduce SIDS risk
• Model appropriate positioning for family
Recommend supine and flat sleeping at ~ 32 weeks
And if the baby is still spelling?
• Most “spells” are not related to feeding, reflect immaturity that
requires ongoing in-house monitoring
GER – Treatment
9/13/2019
10
© 2019 28
Feeding strategies
• Longer feeding duration and lower milk flow rates
associated with fewer GER events (median rate still
25.6 minutes)
• However, this is at nutritional cost –
• IL and protein bind to tubing
• Recommend feeding target to be given over 30
minutes
GER – Treatment
© 2019 29
Thickened feedings with rice cereal
• RCT of thickened feedings in term infants reduced
episodes of regurgitation
In preterm infants, small trials have been done:
• 1 trial of starch-thickened formula, total number of
GER episodes were unchanged compared with
standard formula
GER – Treatment
© 2019 30
Elemental or hydrolyzed protein formulas
• Reduce GI transit time
• Reduce symptoms in term infants with symptomatic
GER
In preterm infants
• Fewer reflux episodes as measure by MII, but did not
reduce behavioral signs of GER (Logarajha et al)
GER – Treatment
9/13/2019
11
© 2019 31
Pharmacologic Treatment
• H2 blockers
• Decease acid secretion
• Not studied in preterm infants to assess effect on clinical
symptoms
• Increased risk of NEC
• Impact on microbiome
• PPI
• Ineffective in reducing GER signs in infants
GER – Treatment
© 2019 32
Pharmacologic Treatment
• Prokinetic agents
• None have shown to decrease GER symptoms in preterm
infants
• All linked to higher risk for pyloric stenosis (erythromycin),
cardiac arrhythmia (erythromycin) or neurologic side effects
(metoclopramide)
GER – Treatment
© 2019 33
How to counsel families:
• If stomach is full or position changes quickly, that could
cause GER
• GER rarely causes distress and usually goes away as
digestive tract matures, usually by six months, but can take
about a year
• Does not require drug treatment
• Try to keep baby upright for 30-60 minutes after feedings
• Feeding smaller, more frequent amounts can be helpful
GER – Treatment in preterm infants
9/13/2019
12
© 2019 34
Consistent message to family from all team members:
• “Non pathologizing” of a normal developmental process
GER – Treatment
© 2019 35
It’s messy – it’s not pathologic
GER – A challenge and nuiscance
© 2019 36
Conditions with higher prevalence of GER
• Cerebral palsy
• Developmental delay
• Esophageal atresia/TE fistula
• CDH
• Obesity
9/13/2019
13
© 2019 37
Term infants
If GERD suspected:
• Have mother avoid milk and dairy products for 2-4
weeks if breastfeeding
• Formula – consider extensively hydrolyzed formula
• Thickened formula – with one tablespoon of rice
cereal per 1-2 ounces of formula
• Formulas designed for reflux
• Avoid overfeeding, don’t refeed after spitting up
• Hold upright after feedings
• Smaller volumes, more frequently
© 2019 38
Clinical Report, AAP, Committee on Fetus and Newborn
Diagnosis and Management of Gastroesophageal
Reflux in Preterm Infants. Pediatrics July, 2018
AAP Recommendations
© 2019 39
GER and Preterm Infants
Recognition and education of all NICU staff and parents that:
• 1. Gastroesophageal reflux (GER) is a normal occurrence in preterm infants associated with
frequent and developmentally appropriate Transient Lower Esophageal Sphincter Relaxation
(TLESR) events; it is almost always not pathologic.
• 2. In studies measuring true occurrence of GER, signs attributed to GER including feeding
intolerance, apnea, bradycardia, desaturation, feeding-associated arching, irritability and
recurrent emesis have not been shown to be associated with documented reflux.
• 3. Positioning (e.g. elevation of the head of bed) has not been shown to be effective in
decreasing signs attributed to reflux; if infants have had the head of the bed elevated, the
head of bed should be made flat by 32 weeks corrected gestational age and babies should
be supine to promote safe sleep practices in preparation for going home. Babies admitted at
32 weeks corrected gestational age or greater should not have the head of bed elevated
without a provider order.
• 4. Altering of feedings (e.g. infusion of feedings over extended periods of time) can reduce
the nutritional value of breastmilk from significant fat loss due to increased time in contact
with tubing; by 32 weeks corrected gestational age, it is recommended that all feedings be
given over no longer than 30 minutes (refer to feeding guidelines).
• 5. There is no role for medications for treatment of suspected GER in premature infants.
Memo to all team members
9/13/2019
14
© 2019 40
Summary
© 2019 41
• Spit happens
Summary
© 2019 42
Take home points
• Gastroesophageal reflux is a frequent occurrence in all newborns, especially preterm newborns
• Avoid the “pathologizing” of this normal developmental phenomenon
• There is no role for medications for GER in premature infants
• Manipulations of feedings has minimal impact, and can be detrimental
• Strive to have all infants on their back to sleep, with head of the bed flat starting at 32 weeks
9/13/2019
15
© 2019 43
Reference list
• Eichenwald EC and AAP Committee on Fetus and Newborn. Diagnosis and management of gastroesophageal reflux in preterm infants. Pediatrics 2018;142:e20181061
• Czinn SJ and S. Blanchard. Gastroesophageal reflux disease in neonates and infants. Pediatr Drugs 2013;15:19-27
• Funderburk A, Nawab U et al Temporal association between reflux-like behaviors and gastroesophageal reflux in preterm and term infants. J Pediatr Gastroenterol Nutri 2016: 62: 556-561
• Peter CS, Sprodowski N et al Gastroesophageal reflux and apnea of prematurity: no temporal relationship Pediatrics 2002, 109:8-11
• DiFiore JM Arko et al Apnea is not prolonged by acid gastroesophageal reflux in preterm infants. Pediatrics 2005;116:1059-1963
• Loots C Kritas et al Body positioning and medical therapy for infantile gastroesophageal reflux symptoms J Pediatr GastroenterolNutri 2014;59:237-43
• Jadcherla SR Chan CY et al. Impact of feeding strategies on the frequency and clearance of acid and nonacid gastroesophageal reflux events in dysphagic neonates J Parenter Enteral Nutri 2012: 36: 449-455
• Garzi A, Messina M et al An extensively hydrolysed cow’s milk formula improves clinical symptoms of gastroesophageal reflux and reduces the gastric emptying time in infants. Allergol Immunopathol (Madr) 2002;30:36-41
• Logarajaha V, Onga C et al PP-15 the effect of extensively hydrolyzed protein formula in preterm infants with symptomatic gastroesophageal reflux J Pediatr Gastroenterol Nutr 2015;61:526
• Guillet R Stoll BJ et al NICHD NRN Association of H2-blocker therapy and higher incidence of NEC in VLBW infants Pediatrics 2006;117:
• Orenstein SR, Hassall E et al. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease J Pediatr 2009;154:514-520
• Ho, T, Dukhovny D et al. Choosing wisely in newborn medicine: five opportunities to increase value Pediatrics 2015: 136. Available at www.pediatrics.org.cgi/content/full/136/2/e482
© 2019 44
• Comments welcome!
Thank you!